Rosie Thein

Overview

Dr. Thein is interested in infectious disease and cancer research, and mathematical modeling methods for health and economic evaluation. She is working to further understand the health and economic implications of cancer prevention and treatment. The ultimate goal of her research is to achieve improved early detection, diagnosis and management strategies for cancer. Thein currently evaluates large, population-based databases to assess health outcomes and health service utilization among patients with hepatocellular carcinoma at a community level. She also conducts decision analytic models, mathematical models and cost-effectiveness analyses to help inform public health policy decision making. This helps to mitigate the burden of disease and improve care and quality of life for individuals.

Contact Information

Dr. Rosie Thein

Telephone: 416-978-2020

Affiliations

2010 - Assistant Professor, Division of Epidemiology, Dalla Lana School of Public Health (DLSPH), Faculty of Medicine, University of Toronto.
2010 - OICR Investigator I, Ontario Institute for Cancer Research (OICR).
2010 - Investigator, Toronto Health Economics and Technology Assessment Collaborative (THETA).
2010 - Visiting Fellow, The Kirby Institute (formerly National Centre in HIV Epidemiology and Clinical Research), Faculty of Medicine, University of New South Wales, Sydney, Australia.
2008 - 2010Lecturer, Viral Hepatitis Clinical Research Program, National Centre in HIV Epidemiology and Clinical Research, Faculty of Medicine, University of New South Wales, Sydney, Australia.
2006PhD (Public Health), University of New South Wales, Sydney, Australia.
2006 - 2008Postdoctoral Research Fellow, Division of Clinical Decision-Making & Health Care Research, Toronto General Research Institute, University Health Network/University of Toronto, University Health Network (UHN).
2004 - 2005Project Manager, National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney, Australia.
2001 - 2004Research Assistant/Coordinator, National Centre in HIV Epidemiology and Clinical Research (NCHECR), University of New South Wales, Sydney, Australia.
1997MPH, University of California, Berkeley, USA.
1991 - 2000Medical Officer, Department of Obstetrics and Gynaecology, Labasa Hospital, Ministry of Health, Public Service Commission, Fiji.
1982 - 1988Medical Officer, Obstetrics and Gynaecology, Ministry of Health, Burma.

Research Output

  • Pattullo V, Thein HH, Heathcote EJ, Guindi M
    Combining semi-quantitative measures of fibrosis and qualitative features of parenchymal remodeling to identify fibrosis regression in hepatitis C: a multiple biopsy study
    • (Histopathology; accepted Jan 10, 2012).
  • Pham B, Stern A, Chen W, Sander B, John-Baptiste A, Thein HH, Gomes T, Wodchis WP, Bayoumi A, Machado M, Carcone S, Krahn M
    Preventing pressure ulcers in long-term care: a cost-effectiveness analysis
    • Arch Intern Med 2011; 171: 1839-47
  • Thein HH, Walter SR, Gidding HF, Amin J, Ward K, Law MG, George J, Dore GJ
    Trends in incidence of hepatocellular carcinoma after diagnosis of hepatitis B or C infection: a population-based cohort study, 1992-2007
    • J Viral Hepat. 2011;18:e232-41
  • Walter SR, Thein HH, Amin J, Gidding HF, Ward K, Law MG, George J, Dore GJ
    Trends in mortality after diagnosis of hepatitis B or C infection: 1992-2006
    • J Hepatol. 2010; 54:879-886
  • Thein HH, Yi Q, Dore GJ, Krahn MD
    Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: A meta-analysis and meta-regression
    • Hepatology 2008; 48:418-431